IFIH1 and autoimmune disease: This a notable limitation, particularly in light of numerous case reports that have been published during and after the pandemic documenting the onset of autoimmune diseases, including myositis and specifically anti-melanoma differentiation-associated protein 5 (MDA5) autoantibody-positive DM following COVID-19 vaccination (5, 39–41).